Robotic Surgery Services Market Report 2026

The robotic surgery services market size has grown rapidly in recent years. It will grow from $1.39 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to expansion of minimally invasive surgery adoption, rising surgeon acceptance of robotic systems, growth in complex surgical procedures, increasing hospital investments in advanced operating rooms, improvements in robotic instrument design.

The robotic surgery services market size is expected to see rapid growth in the next few years. It will grow to $2.62 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to growing demand for outpatient robotic surgeries, rising investments in next-generation surgical robotics, expansion of robotic procedures across specialties, increasing integration of AI-assisted surgical planning, growing focus on outcome-based surgical care. Major trends in the forecast period include increasing adoption of minimally invasive robotic procedures, rising demand for procedure-specific robotic platforms, growing integration of advanced surgical imaging systems, expansion of robotic surgery training programs, enhanced focus on surgical precision and outcomes.

The increasing prevalence of chronic diseases is expected to drive the growth of the robotic surgery services market in the coming years. Chronic diseases are long-term medical conditions that generally progress slowly and require ongoing care or management, including conditions such as cardiovascular diseases, diabetes, respiratory illnesses, and certain cancers. The rise in chronic diseases is largely attributed to the growing prevalence of sedentary lifestyles, which contribute to poor metabolic health, reduced physical resilience, and a higher risk of developing long-term conditions that persist without regular intervention. Robotic surgery services help address this growing challenge by enabling precise, minimally invasive procedures that enhance treatment outcomes, shorten recovery times, and facilitate more efficient management of complications related to chronic diseases. For example, in September 2025, the British Heart Foundation, a UK-based charity, reported that over 7.6 million people in the UK - more than 4 million men and over 3.6 million women - are living with cardiovascular disease. Projections indicate that, driven by an aging population and improved survival rates, the number of affected individuals may increase by around 1 million by 2030 and approximately 2 million by 2040. Consequently, the rise in chronic diseases is supporting the growth of the robotic surgery services market.

Key companies in the robotic surgery services market are focusing on developing innovative technologies, such as the Da Vinci Xi Robotic Surgical System, to deliver reliable services. The Da Vinci Xi Robotic Surgical System provides an effective, minimally invasive alternative to both open surgery and laparoscopy. For instance, in June 2023, Apollo Hospitals Enterprise Limited, an India-based healthcare provider, introduced the Da Vinci Xi Robotic Surgical System. This surgical robot is used to treat a wide range of conditions, including cancer, colorectal disorders, gynecologic conditions, heart disease, head and neck disorders, thoracic disorders, and urological disorders. It features HD cameras for superior visualization and offers greater dexterity than the human hand, with the ability to rotate 360 degrees.

In October 2025, Zimmer Biomet, a US-based provider of orthopedic implants, digital surgery platforms, and robotic-assisted surgical technologies, acquired Monogram Technologies for an undisclosed amount. Through this acquisition, Zimmer Biomet aims to enhance its orthopedic robotics portfolio by integrating advanced semi-autonomous and fully autonomous robotic capabilities, improving precision, expanding procedural applications, and accelerating innovation across its surgical technology ecosystem. Monogram Technologies, based in the US, provides AI-driven orthopedic robotics solutions, including CT-based, surgeon-guided, and autonomous robotic systems for total knee arthroplasty.

Major companies operating in the robotic surgery services market are Tenet Healthcare Corporation, HCA Healthcare Inc, Asklepios Kliniken Verwaltungsgesellschaft Mbh, Apollo Hospitals Enterprise Ltd, Bumrungrad International Hospital, Fortis Healthcare, Bangkok Hospital, Spire Healthcare Group plc, Saudi German Hospitals Group, Raffles Medical Group, Medtronic Australasia, Zimmer Biomet Robotics, Asensus Surgical, Intuitive, Medrobotics Corporation, Smith And Nephew, Restoration Robotics, Hansen Medical, Stryker Corporation, Mazor Robotics, Renishaw Plc, Stereotaxis Inc, Corindus, CMR Surgical Ltd, Johnson And Johnson MedTech.

North America was the largest region in the robotic surgery services market in 2025. Western Europe was the second largest region in the global robotic surgery services market share. The regions covered in the robotic surgery services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic surgery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the robotic surgery services market by increasing costs of imported robotic systems, surgical instruments, imaging components, precision motors, and electronic control units. Hospitals and ambulatory surgery centers in North America and Europe are most affected due to dependence on imported robotic platforms, while Asia-Pacific faces cost pressures on system procurement and service expansion. These tariffs are raising procedural costs and slowing adoption among smaller facilities. However, they are also supporting regional servicing capabilities, local assembly of accessories, and long-term investments in domestic surgical robotics ecosystems.

The robotic surgery services market research report is one of a series of new reports that provides robotic surgery services market statistics, including robotic surgery services industry global market size, regional shares, competitors with a robotic surgery services market share, detailed robotic surgery services market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery services industry. This robotic surgery services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Robotic surgery is a type of minimally invasive surgery in which surgeons make a series of very small incisions and use tiny surgical instruments within a patient’s body. It involves performing surgical procedures with tools attached to a robotic arm, enabling highly precise operations.

Robotic surgery services are applied across various fields, including general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and more. General surgery focuses on the most common surgical procedures, treating areas such as the abdomen, breasts, head and neck, blood vessels, and digestive tract. General surgeons also manage the care of patients who have sustained injuries or have conditions or abnormalities requiring surgical intervention. The key sectors include hospitals and ambulatory surgery centers (ASCs), and the market encompasses components such as systems, accessories, and services.

The robotic surgery services market includes revenues earned by entities by providing robotic gynecological services, robotic prostate surgery services, robotic kidney surgery services, and robotic colorectal surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.